Manhattan Scientifics Inc (MHTX)

[jim30jen]

ssc, As you know, it doesn't take a different mrx machine for every type of cancer but different labeling of nano particles for different cancers that cause the NPs to bind to cancer cells. The mrx then detects the bound particles in a group that indicates a tumor of the same type of cancer as the labeling.

Dr. Flynn's testing was with HER2 breast cancer because his wife had it.

Dr. Robert Bast at MDA, an ovarian cancer specialist, was one of the first, outside of Senior Scientific, to show interest in the technology. Also, it could be that MDA was looking for the shortest road to the greatest benefits of the technology when they chose to validate it on ovarian cancer first.

When human trials begin at MDA, expect the mrx to be tried on multiple types of cancers including breast cancer.